3,905 results on '"hemostatic disorders"'
Search Results
152. Impact of Balanced Crystalloid and Colloid Infusion on Haemostasis in Healthy Male Volunteers
153. Coagulopathy in Acute Aortic Syndrome (SAACAOG)
154. The Glycocalyx in COVID-19 Patients. A Pilot Study (Glycovid-19)
155. Hemostasis Assesment After Application of Lyophilisate Collagen in Nail Surgery
156. To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
157. Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients
158. BT200 in Hereditary Bleeding Disorders
159. A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic (RAPID-BRAZIL)
160. Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
161. Follow-up of Critical COVID-19 Patients (FUP-COVID)
162. DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic (DAPHNE)
163. Mitochondrial Dysfunction in Trauma-related Coagulopathy
164. Heparin Like Effect in Acute Variceal Bleeding
165. A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors (explorer™4)
166. A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
167. Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
168. Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
169. Human Fibrinogen Concentrate in Pediatric Cardiac Surgery (RiaSTAP)
170. A Comparison of General Versus Peripheral Nerve Block for Lower Extremity Amputation in Diabetic Patients With Bleeding Tendency: a Retrospective Study
171. Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
172. Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women
173. Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease (EDGAR)
174. Incidence and Predictors of Bleeding Diathesis Development Due to DIC in Cirrhosis and ACLF Patients Undergoing CRRT
175. Dexmedetomidine and Blood Coagulation
176. Comparison of Two D-Dimers Dosing Techniques (COMPADDI)
177. Thrombin Generation in Liver Transplant Surgery
178. Coagulopathy and SIRS During ECC in Intensive Care
179. Thromboelastometry-identified Haemostatic Changes in Isolated Traumatic Brain Injury (THROMBIN)
180. Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections
181. COVID-19 Associated Coagulopathy in Egypt
182. Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) (HIPEC-COAG)
183. Trauma Induced Coagulopathy and Inflammation (TrICI)
184. Vascular Abnormalities and Bleeding Diathesis
185. Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial. (VISCOTRAUMA)
186. Copeptin and Psychological Stress of Medic During COVID-19 Pandemic (COVID-19)
187. XIENCE 28 Global Study
188. Gyeongsang National University Hospital Registry (GNUH)
189. The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures
190. Rare Bleeding Disorders in the Netherlands (RBIN)
191. Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
192. Determination of ClotPro Paediatric Reference Range Study
193. Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy (SCARLET)
194. Kid Cards: Teaching Kids About Medicines
195. ROTEM-guided Transfusion Protocol in Attempt to Reduce Blood Transfusions in Major Oncological Surgery (ROTEM-SUR)
196. Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (guardian™4)
197. Coagulopathy in Cardiac Surgery
198. The Early Coagulopathy for the Prognosis in Sepsis
199. A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A (pathfinder™5)
200. Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A (pathfinder™2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.